ARCHIVES

Combined analysis moves Herceptin to adjuvant setting in breast cancer.

This article is from The Cancer Letter archive.

Vol. 31 No. 21 | May 27, 2005

Download PDF Visit The Full Archive

Related Articles

NCI Director Says Gallo’s Work On HIV Should Have Been Recognized.

October 10, 2008

White House Picks Harold Varmus For NCI

May 21, 2010

Duke Researchers Retract Paper from Blood; Dozens of Retractions of Potti’s Work Expected

September 9, 2011

Lynch Named Director, Yale Cancer Center

February 27, 2009

In Brief: DRCA Board Split On Guidelines For CCOP Remains Unresolved; Chop Implementation Talks Starting

December 4, 1981

ACS Medals Of Honor To Bonadonna, Hsu, Louis Sullivan

December 13, 1991